ImpediMed wins FDA clearance for SOZO sarcopenia assessment, extending one scan beyond lymphedema monitoring
ImpediMed’s new FDA clearance adds sarcopenia risk assessment to the SOZO platform, potentially allowing muscle-loss monitoring alongside existing fluid and body-composition measurements.